The role of degraded skin elastin contributing to a systemic pro-inflammatory state linked to progression of lung disease is unknown, though studies evaluating the utility of a byproduct of elastin cleavage, desmosine, as a biomarker of pulmonary disease have been inconclusive to date [36]. This evidence concerns the gene ELN and lung disorder.